顶尖大学研究、跨境数据交流以及进入中国内地庞大市场的机会，吸引了日本企业乐敦制药在香港开展临床试验，使其成为该市政府旗舰投资计划下首个合作的日本公司。
Top university research, cross-border data exchanges and access to mainland China’s large market have attracted Japanese firm Rohto Pharmaceutical to conduct clinical trials in Hong Kong, making it the first company from the country to partner with the city’s government under a flagship investment initiative.
乐敦制药以其非处方眼科护理和护肤产品闻名，是吸引重点企业办公室（OASES）最新一批招募的18家公司之一，该办公室……
Rohto, known for its over-the-counter eye care and skincare products, is among the latest batch of 18 firms recruited by the Office for Attracting Strategic Enterprises (OASES), a...